Found: 4
Select item for more details and to access through your institution.
Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 1, p. 39, doi. 10.1007/s00277-011-1242-z
- By:
- Publication type:
- Article
Clonal selection in therapy‐related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 488, doi. 10.1111/ejh.13390
- By:
- Publication type:
- Article
Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 780, doi. 10.1002/ajh.23509
- By:
- Publication type:
- Article
Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA.
- Published in:
- Lymphoma (2090309X), 2014, p. 1, doi. 10.1155/2014/205215
- By:
- Publication type:
- Article